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Highlights 
 This project leverages Indiana’s Opioid State Targeted Response efforts.
 Pilot work demonstrates the necessity of flexibility in pragmatic trial design.
 All three milestones were reached and implementation of protocols was successful.
 Data access, recruitment, and identification of hospitals required refinements.
 The subsequent pragmatic trial will help inform ED-based peer supports much faster.
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Abstract 
Solving the opioid crisis requires immediate, innovative, and sustainable solutions. A 
number of promising strategies are being carried out by U.S. states and territories as part of 
their Opioid State Targeted Response (STR) plans funded through the 21st Century Cures Act, 
and they provide an opportunity for researchers to assess effectiveness of these interventions 
using pragmatic approaches. This paper describes a pilot study of Project Planned Outreach, 
Intervention, Naloxone, and Treatment (POINT), the intervention that served as the basis for 
Indiana’s STR-funded, emergency department (ED)-based peer specialist expansion that was 
conducted in preparation for a larger, multisite pragmatic trial. Through the pilot, we identified, 
documented, and corrected for challenges encountered while implementing planned study 
protocols. Per the project’s funding mechanism, the ability to move to the larger trial was 
determined by the achievement of 3 milestones: (1) successful replication of the intervention; 
(2) demonstrated ability to obtain the necessary sample size; and (3) observe a higher level of 
engagement in medication for addiction treatment in the POINT group compared to standard 
care. Overall implementation of the study protocols was successful, with only minor 
refinements to proposed procedures being required in light of challenges with (1) data access, 
(2) recruitment, and (3) identification of the expansion hospitals. All three milestones were 
reached. Challenges in implementing protocols and reaching milestones resulted in refinements 
that improved the study design overall. The subsequent trial will add to the limited but growing 
evidence on ED-based peer supports. Capitalizing on STR efforts to study an already scaling and 
promising intervention is likely to lead to faster and more sustainable results with greater 
generalizability than traditional, efficacy-focused clinical research.  
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1.1. Introduction1 
Signed into U.S. law in December of 2016, the 21st Century Cures Act authorized $1 
billion in funding to support prevention and treatment initiatives to curb the opioid epidemic 
(Bonamici, 2016). Allocation of these funds to U.S. states and territories occurred over 2 years 
through the State Targeted Response (STR) to the Opioid Crisis grant mechanism managed by 
the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA, 2016). Thirty-
one abstracts from the 57 awarded STR grants mention some form of peer services—i.e., 
supports provided by paraprofessionals with lived experience in recovery—as being central to 
their plans (SAMSHA, 2017). Furthermore, 6 of these abstracts specifically highlight plans to 
implement peer recovery specialists in emergency department (ED) settings. Diffusion of this 
practice through STR funding presents an excellent opportunity to assess the effectiveness of 
ED-based peer services. In this paper, we describe a pilot study that leveraged Indiana’s opioid 
STR efforts to lay the groundwork for a pragmatic trial of Project Planned Outreach, 
Intervention, Naloxone, and Treatment (POINT), an ED-based peer support intervention aimed 
at connecting people with OUD to medication for addiction treatment (MAT; in the context of 
OUD treatment, this refers to the use of any of three evidence-based medications: methadone, 
buprenorphine, or naltrexone). Our experiences conducting this work emphasize the value of 
flexible research designs when seeking to take advantage of real-world research opportunities 
such as those presented by the STR funds. 
                                                     
1
 Abbreviations used in this article: emergency department (ED), medication for addiction treatment (MAT), opioid 
use disorder (OUD), peer recovery coach (PRC), Planned Outreach, intervention, Naloxone, and Treatment (POINT), 
prescription drug monitoring program (PDMP), standard care (SC), State Targeted Response (STR) 
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Indiana received approximately $22 million in STR funding to implement its plan to 
combat the opioid epidemic within its borders. One of the primary components of this plan is 
the Recovery Coach and Peer Support Initiative (RCSI). The goal of this initiative is to insert 
peers into the ED setting to engage with patients who present after an opioid overdose and 
connect them to MAT. The logic underlying this approach is that, given it is a frequent point of 
contact people living with OUD have with the formal healthcare system (Masson et al., 2002; 
Mor, Fleishman, Dresser, & Piette, 1992; Sohler et al., 2007), the ED is in a unique position to 
identify, develop, and implement solutions to improve outcomes for this population (Anderson, 
Hsieh, & Alter, 2016; Duber et al., 2018). There is indeed burgeoning evidence supporting ED-
based interventions for OUD (Hawk & D’Onofrio, 2018), as prior studies have demonstrated 
feasibility of and patient receptiveness to opioid education and naloxone distribution (Dwyer et 
al., 2015) and positive outcomes for patients who begin buprenorphine treatment within the 
ED setting (Berg et al., 2007; D’Onofrio et al., 2017, 2015; Johns, Bowman, & Moeller, 2018). 
Separate literature demonstrates promising and growing evidence that peers can improve 
recovery-oriented outcomes for OUD (Bassuk, Hanson, Greene, Richard, & Laudet, 2016; Reif et 
al., 2014), and these improvements are largely viewed as an effect of peers’ ability to better 
connect with patients than clinicians who do not have lived recovery experience (Powell, 
Treitler, Peterson, Borys, & Hallcom, 2019; Salzer, 2002; White & Evans, 2014). However, while 
prior programs have demonstrated some success in implementing peers in ED settings and 
achieving encouraging service-related outcomes (The Providence Center, n.d.; Powell et al., 
2019; Waye et al., 2019), there is no current evidence supporting their effectiveness for 
improving treatment or recovery outcomes for people living with OUD.  
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Developed by the second author (KB), POINT is the intervention Indiana drew partial 
inspiration from when developing the RCSI. Started as a quality improvement initiative at 
Indianapolis’s Eskenazi Hospital in 2016, POINT employs an intensive outreach and follow-up 
approach facilitated by peer recovery coaches (PRCs) who are trained and certified to assist 
individuals in addiction recovery (ICAADA, n.d.; Doukas, 2015; Sightes et al., 2017). A member 
of the POINT team (i.e., a PRC or care coordinator with specialized training) meets vulnerable 
patients in the ED after opioid overdose and offers them an array of harm reduction-informed 
services (e.g., risk assessment, HIV and HCV testing, and a naloxone kit) and treatment referrals 
with follow-up to either a MAT provider, detoxification services, or an inpatient treatment 
setting. Close collaboration with MAT providers ensures POINT patients have their first 
assessment within 1-2 business days of ED discharge. After this point, PRCs provide phone or in-
person support to navigate barriers to the recovery process, focusing special attention on 
patients undergoing transitions of care. The entire care transition process takes between 2 
weeks and several months, and POINT leaves the door open so patients can re-engage at any 
time they require help overcoming recovery barriers. POINT also provides supports to patients 
who are not ready for treatment for the purposes of building a relationship that could lead to 
MAT linkage at a time when the patient is more accepting of services. At this time, POINT does 
not initiate MAT within the ED due to health care system and political barriers, which, despite 
evidence for effectiveness, have prevented the uptake of ED-initiated buprenorphine within 
much of Indiana and the nation (Lowenstein, Kilaru, Perrone, Hemmons, Abdel-Rahman, 
Meisel, & Delgado, 2019). 
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At the end of its first year, the Eskenazi POINT program achieved some notoriety within 
Indiana due to its early accomplishments. For instance, of 97 patients seen by POINT staff from 
February to December of 2016, 85% (n =82) agreed to participate in services. Of these, 44% (n = 
37) were verified as attending at least one scheduled follow-up appointment and 50% (n =19) 
of those who made it to their first appointment were still engaged in treatment at 6-month 
follow-up. Despite these positive early results, POINT and ED-based peer support interventions 
more generally lack rigorous evidence (i.e., randomized-controlled trials) required to be 
considered “evidence-based practices.” While supporting state-wide implementation of an 
intervention without demonstrated efficacy could be considered unwise, the reality is that 
community stakeholders often make decisions to adopt or implement interventions based on 
factors other than the empirical evidence underlying them. Meanwhile, the gravity of the 
opioid epidemic requires innovative and promising solutions that can be rapidly scaled, an 
approach that is incompatible with the traditional research-to-practice pipeline (Office of 
Science and Technology, 2018; Bonell, Fletcher, Morton, Lorenc, & Moore, 2012; Bowen & Zwi, 
2005; Brownson, Royer, Ewing, & McBride, 2006; Milat et al., 2014; Volkow & Collins, 2017). 
What is required in cases such as this is a more pragmatic practice-to-research approach that 
can establish an evidence-base for interventions as they are being rolled-out under real-world 
conditions (Geng, Peiris, & Kruk, 2017; Westfall, Mold, & Fagnan, 2007). As such, the current 
study seeks to develop the evidence-base for POINT through a pragmatic, multisite clinical trial, 
a useful approach for making causal inferences within the context of real-world programmatic 
scale-up (Cheng et al., 2013; Geng et al., 2017). Indeed, this work is supported by a unique 
funding mechanism from the National Institute on Drug Abuse that recognizes the need for 
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such approaches, as it only supported projects with strong researcher-state government 
collaborations that could leverage opportunities made available by STR funding to test 
approaches to expanding and/or linking clients to MAT (National Institutes of Health, 2017). 
The government partner in this project is the Indiana Division of Mental Health and Addiction, 
which is the state entity overseeing STR implementation. 
The funding mechanism specifically supports one year of start-up and pilot activities 
followed by a larger 3-year study. This paper focuses specifically on the 6-month pilot 
conducted within the first year of funding to prepare our team for a full-scale clinical trial. In 
the Material and Methods section, we provide an overview of the larger trial as it was 
conceptualized at the start of the pilot phase before providing specific details related to the 
pilot. Our results focus on the accomplishment of our pilot goals and necessary adjustments to 
the proposed design prior to the full trial as determined through challenges encountered 
related to the implementation of our research protocols and the attainment of 3 pre-identified 
milestones.  
2.1. Material and Methods 
This is a 6-month pilot designed to lead to a larger, multi-site cluster randomized trial. 
As pilots are a scaled-down version of a larger study, all protocols and procedures implemented 
reflected those we aimed to employ in the subsequent trial, and we therefore describe the 
methods proposed for the full trial before detailing the approach taken in the pilot. 
2.1.1. Proposed clinical trial 
Based on the original proposal, the subsequent larger trial was to be conducted at 3 
Indiana hospitals comprising the pilot site and two additional hospitals receiving RCSI funding to 
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be identified at a later date. The trial has two arms: (1) POINT and (2) standard care (SC), 
consisting of referral to an addiction treatment provider. Time-based cluster randomization 
happens at the shift-level, with the work day being divided into two shifts (8am-3:59pm and 
4pm-11:59pm) so there is always one POINT and one SC shift scheduled each day. Cluster 
randomization such as this is preferable within the context of a pragmatic trial since it is not 
practical or ethical to expect ED staff to take time away from care to assign patients to a 
treatment arm (Bonell et al., 2012; Boutron, Ravaud, & Moher, 2016; Ford & Norrie, 2016; 
Plaisance et al., 1999; Touzet et al., 2014).  
At the time of funding, proposed study eligibility criteria for patients included being: (a) 
18 or older; (b) presenting to the ED during the hours of the day the study was running (i.e., 
8am to 11:59pm); (c) revived from a non-fatal opioid overdose; and (d) medically stable. 
Patients were excluded if they were cognitively incapable of providing consent as determined 
by an ED provider. Eligible patients were to be identified by an emergency medical services 
alert indicating they had been given naloxone (an opioid-overdose cure) prior to arriving by 
ambulance to the hospital, and assignment to a study arm determined by the time of ED 
admission. 
Consent for the POINT arm was to be collected by a POINT PRC when they approached 
the patient for services (PRC services are still offered if the patient does not consent to study 
enrollment). A waiver of informed consent was sought for the SC arm, as all data were to be 
deidentified by a third party before transfer to the researchers. In addition, it was determined 
unfeasible to have ED staff collect consent from patients during the course of care, nor was it 
ethical for SC consent to be requested by PRCs since asking them to interact with patients and 
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not provide services might have a negative impact on their personal recovery. All post-ED 
admission data were to be obtained through secondary sources including: the Indiana Network 
for Patient Care (i.e., a health information exchange covering a large portion of the state); 
Medicaid claims; state-level opioid prescribing, as well as criminal justice, child welfare, and 
county-level coroner data. Together, these sources will help us measure a variety of health-
related (e.g., MAT engagement, duration of MAT treatment, subsequent overdose, hospital 
admissions, and mortality) and social outcomes (e.g., child welfare and criminal justice 
involvement). This proposed study design, which was tested in the pilot, was approved by the 
Indiana University Institutional Review Board. 
2.1.2. Pilot setting 
The setting for the pilot was Indiana University Health Methodist Hospital, a Level I 
Trauma Center located in downtown Indianapolis, Indiana. Methodist was chosen as the pilot 
site because: (a) the hospital leadership had already expressed interest in adopting and 
implementing POINT; (b) Indianapolis EMS has a high rate of overdose encounters, with more 
than 1,855 people reported to have received naloxone on an EMS run in 2017 (Watson et al., 
2018); and (c) it was in close proximity to the research team, allowing for easy identification 
and correction of issues that might arise related to protocols and procedures. 
2.1.4. Pilot measures 
As is appropriate for a pilot study (Arain, Campbell, Cooper, & Lancaster, 2010), our 
focus was largely on identifying, documenting, and correcting for challenges encountered that 
were likely to impede the success of the resulting clinical trial. Additionally, the funding 
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mechanism required 3 researcher-defined milestones that were to be obtained in order to 
demonstrate readiness to move from the pilot to the larger study. 
Milestone 1 focused on the successful replication of POINT at Methodist, defined as 
successfully implementing 75% of POINT elements that were determined critical through 
observations of the original Eskenazi program. These 13 elements include: (1) a multi-method 
system to alert PRCs to ED opioid overdose admissions; (2) dedicated ED office space for POINT 
staff; (3) initial patient engagement occurs in the ED; (4) PRC-based services; (5) PRCs have lived 
experience with opioid use; (6) PRCs are philosophical and logistically supported by ED staff; (7) 
patient choice in services/treatment; (8) transportation provided to initial service/treatment 
appoints; (9) formal relationship between POINT program and a MAT provider (e.g., specialized 
referral process, provider involved in POINT administration); (10) walk-in hours for POINT 
patients established at a primary MAT provider; (11) relationships developed with alternative 
treatment providers ; (12) financial support for non-billable services; and (13) naloxone 
education and distribution. 
The goal of Milestone 2 was to demonstrate our ability to obtain the necessary sample 
size for the resulting trial. The sample size for the subsequent larger trial is n = 712 participants 
(n = 356 in each arm), which is necessary to provide enough patients to obtain a full year of 
follow-up data to detect a minimum 6% reduction in subsequent overdose (measured as 
subsequent ED overdose admissions combined with overdose mortality) at 80% power 
assuming a 12% rate of subsequent overdose for the SC arm at the 5% significance level (a 
conservative calculation based on observed subsequent overdose rates at Eskenazi and 
Indianapolis-wide EMS). We based the sample size on subsequent overdose since it was a 
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required outcome stated in the funding mechanism and the most distal and difficult of all our 
outcomes to obtain. Consequently, we should be able to detect a difference in all other 
variables of interest. To reach the required sample size would require each hospital to enroll 
average of 4 patients per arm for each month of the larger study. Because Methodist has one of 
the highest overdose admission rates for the state, we set our recruitment goal for the 
milestone at n = 30 POINT patients (an average of 5 patients a month over the pilot). We 
assumed reaching this number would guarantee our ability to also reach sufficient enrollment 
for SC patients since the proposed waiver of informed consent meant we would not have to 
worry about refusals in this arm. 
Finally, we proposed for Milestone 3 that there would be a higher level of MAT 
engagement in the POINT group. We defined this as detecting a 10% higher rate in the number 
of POINT patients who initiated MAT compared to SC. Our focus on MAT initiation, rather than 
subsequent overdose (the focus of our sample-size calculation), is because it was unlikely we 
would be able to detect a difference in overdose in just 6 months, whereas MAT initiation 
would ideally occur relatively soon after ED admission. 
3.1 Results 
Formal implementation of the program at Methodist began in November of 2017. All 
PRCs were hired and fully trained by January 20, 2018, and we began offering POINT services on 
January 12, 2018. Our first patient was enrolled into the study on February 13, 2018. The 
official end of the pilot was August 31, 2018. 
3.1.1. Identified challenges and responses 
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Overall implementation of the study protocols went smoothly, with only minor 
refinements to proposed procedures being required in light of specific challenges. These 
challenges and adjustments fall under three categories: (1) data access, (2) recruitment, and (3) 
identification of the expansion hospitals.  
3.1.1.1. Data access. The first challenge we encountered was learning we would be 
unable to access methadone treatment data without signed health information releases from 
study participants per the State of Indiana’s interpretation of the 42 Code of Federal 
Regulations, the legislation pertaining to confidentiality of behavioral health treatment 
information (e-CFR, n.d.). As such, we were unable to use the proposed waiver of informed 
consent for the SC arm. In response to this challenge, we hired research assistants to enroll 
patients on the SC shifts and to provide them with a list of referral resources and information 
about naloxone use and access (resources are provided regardless of the patient’s study 
consent). While the change requires more staffing and activities, it will allow us to both access 
the methadone treatment data and to obtain detailed baseline data from SC patients. As such, 
we constructed a detailed structured interview that included, among other things, questions 
pertaining to: detailed sociodemographics, social support, living arrangements, substance use 
patterns and behaviors, context of the current overdose, past overdose experience, treatment 
history, physical and mental health, and adverse childhood experiences. We also offered 
patients a $10 gift card as an incentive to complete baseline data collection.  
We also experienced a delay in formalizing our relationships with all agencies necessary 
for obtaining secondary data needed for assessing outcomes. While the agreements were not 
completed, the process of establishing them was started with every state-level agency 
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necessary (e.g., Division of Mental Health and Addiction, Office of Medicaid Policy and Planning, 
and Department of Child Services) except for the state’s prescription drug monitoring program 
(PDMP). The PDMP data were our proposed primary source of identifying subsequent opioid 
prescribing and engagement in buprenorphine-based MAT. However, we were able to identify 
an alternate source of obtaining prescribing data through the Surescripts dataset, which is 
managed by the same organization that manages the Indiana Network for Patient Care, and it 
includes dispensation data for several large insurance companies. While the dataset is not 
comprehensive, combining it with Medicaid claims should provide sufficient information for our 
purposes. As an added benefit, the Surescripts dataset contains information on naltrexone-
based MAT, which we would have not been able to detect given our original plan since 
naltrexone is not a controlled substance and its prescribing is thus not recorded in the PDMP.  
3.1.1.2. Recruitment. We faced two specific challenges related to recruitment. The first 
was that less patients were being admitted to Methodist for opioid overdose than expected. 
While the reason for this is not clear, it is possible EMS considered Eskenazi to be the de facto 
hospital for overdose runs since they had been providing POINT services for close to 2 years and 
it was in close enough proximity to Methodist (less than one mile) that distance was likely not a 
consideration for EMS personnel during patient transport. To account for this and improve 
enrollment, we broadened our study eligibility criteria to include any individual seeking care for 
opioid-related issues (e.g., abscess, withdrawal symptoms, endocarditis, opioid intoxication) 
through the ED and to follow-up and try to recruit patients admitted overnight when staff were 
not scheduled—this entailed adding the overnight shifts to our randomization procedure. By 
the end of the pilot, we had recruited a total of 70 participants, 25 were enrolled based on the 
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new eligibility criteria (e.g., 3 opioid intoxication, 5 endocarditis, 6 opioid withdraw, 11 
abscess). 
The second challenge was that the ED workflow did not map well to our shift 
randomization procedures. Specifically, patients were often not ready to be formally 
approached for study enrollment until 3 or more hours after they were admitted. This posed a 
problem since a patient admitted during a POINT shift might not be discharged until the SC shift 
when the PRC was already gone for the day. Because of this, we changed our protocol so that 
eligibility now depends on the time a person is ready for discharge, rather than the time of ED 
admission. This change also required us to develop a method for communication between shifts 
so that PRCs could alert research assistants to patients who were awaiting discharge and vice 
versa.  
3.1.1.3. Identifying expansion hospitals. IU Health applied for and received RCSI funding 
after the pilot began, and we decided it would be optimal to expand to two other IU Health 
locations since we already had access to their system through the pilot. However, IU Health had 
decided to use the RCSI funding to implement telehealth PRCs, which did not fit the POINT 
model. After a series of discussions, IU Health agreed to withhold telehealth implementation at 
two of its locations so they could be utilized for the clinical trial. Together, we settled on the 
hospital locations with the second and third highest rates of opioid overdose admissions after 
Methodist. However, one of the locations had already established a relationship with a 
community health provider who was providing PRC services as part of the RCSI, and the city was 
proposing a moratorium on the number of buprenorphine-based MAT providers that could 
have negatively impacted treatment referrals (and likely the effectiveness of POINT) if passed. 
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Given this limitation, we decided to expand to only one hospital and to employ PRCs and 
research assistants to recruit patients on the overnight shifts to ensure we would be able to 
meet our numbers.  
3.1.2. Milestone attainment 
We successfully met all the proposed milestones by the end of the pilot. Regarding 
Milestone 1 (i.e., successful POINT replication), Methodist had successfully implemented 10 
(77%) of the identified critical elements. Table 1 displays which elements were present and how 
they were implemented in the Methodist setting.  
Table 1 
 
POINT’s identified critical ingredients and their implementation at the Methodist site 
Identified critical ingredient 
Ingredient 
present at 
Methodist Implementation of critical ingredient at Methodist 
1. Multimethod admission alert 
system 
Yes (1) POINT alerted to admission through electronic 
health record and (2) ED staff can call dedicated line 
to request POINT staff. 
2. Dedicated ED office space No POINT space is on behavioral health unit. 
3. Patient engagement in ED Yes Patients are seen in the ED; however, patients 
admitted to hospital are followed up with on inpatient 
unit. 
4. PRC-based services Yes Two certified PRCs were hired by the hospital for the 
project. 
5. PRCs have lived opioid use 
experience 
Yes Both PRCs had opioid use experience. 
6. ED staff support of PRC Yes ED staff demonstrated buy-in by requesting POINT 
services for patients and cooperating with POINT staff 
during researcher observations. 
7. Patient choice in 
treatment/services 
Yes Patients are offered information and assistance 
related to a wide variety of MAT (e.g., methadone, 
buprenorphine, naltrexone) and non-MAT 
treatments/supports. 
8. Transportation provided to 
patients 
Yes Bus cards are provided to patients to make initial 
appointments. 
9. Formal relationship with 
primary MAT provider 
No Relationship with provider who can offer injectable 
naltrexone is established, but this is not the primary 
MAT referral source. 
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10. Walk-in hours with MAT 
provider 
No Not present 
11. Relationships with alternative 
MAT providers 
Yes PRCs established relationships with 2 methadone 
clinics and a buprenorphine clinic. 
12. Financial support for non-
billable services 
Yes Current funding was being provided through research 
funding. 
13. Naloxone education and 
distribution. 
Yes The pharmacy developed a protocol to ensure 
naloxone prescribed to POINT patients is billed to the 
project. 
Concerning Milestone 2 (i.e., obtaining the necessary sample size), Of the 70 patients 
recruited for the pilot, 46 were enrolled in the POINT arm, which exceeds our original goal of 30 
patients. While not a focus of the milestone, it is important to note a total of 26 and 17 of 
eligible patients declined study participation for POINT and SC arms respectively. Furthermore, 
23 eligible patients left the ED before they could be approached and enrolled in the study 
(reasons for this included patient elopement, fast discharge by ED staff, staff was enrolling 
another patient), Additionally, a handful of eligible patients were missed because the previous 
shift for various reasons: 4 were not identified by research staff monitoring admissions; 2 were 
missed because the research staff was enrolling another patient; and 1 was missed because the 
days data collection cancelled due to research staffing shortage.  
We had to redefine measurement of Milestone 3 (i.e., higher MAT engagement in 
POINT arm) given we were unable to obtain secondary data necessary to detect a higher rate of 
MAT engagement within the POINT group. Instead, we were only able to account for those 
POINT patients who we knew a PRC had connected with MAT, which was a total of 7 (15%) 
POINT patients. Given the data limitations, we assumed none of the SC patients successfully 
engaged in MAT during the pilot, an assumption we were comfortable making since data from 
the original POINT quality improvement initiative at Eskenazi demonstrated 9% of POINT 
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patients engaged in MAT compared to < 1% of patients eligible for POINT who did not receive 
services. In light of this information, we determined Milestone 3 to be accomplished. 
4.1 Discussion 
One approach to overcoming the slow development and imperfect uptake of scientific 
evidence for improving OUD outcomes is the use of pragmatic trials to study promising 
interventions with pre-attained community buy-in while they are being implemented. Such 
trials require a flexibility not possible in traditional and highly controlled trials (Haff & 
Choudhry, 2018; Maclure, 2009), and this flexibility often requires a greater focus on external 
over internal validity (Godwin et al., 2003). The pragmatic trial described above specifically aims 
to take advantage of Indiana’s STR-funded RCSI initiative to understand the benefit of providing 
ED-based peer supports to people with OUD, a practice that is scaling at a pace faster than the 
evidence base is developing. Our pilot results demonstrate the necessity of flexibility in 
pragmatic trials and how required compromises have impacted the design of the larger trial to 
follow. While challenges are often thought of in a negative light, our identification and ability to 
address them through alternative solutions is an indicator of our pilot’s success.  
Challenges encountered and lessons learned resulted in two major adjustments that 
will improve the larger trial. While the consent requirement for accessing state-level 
methadone data requires more labor in that we have to staff SC shifts with research assistants, 
we are now obtaining valuable baseline data from patients that will improve our final analyses. 
We have also expanded our inclusion criteria to anyone entering the ED for an opioid-related 
issue. This is also considered a strength since broad inclusion criteria are recommended for 
pragmatic trials to ensure a sample that is more reflective of the type of patient likely to receive 
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services in real clinical practice (Godwin et al., 2003; Roland & Torgerson, 1998; Ware & Hamel, 
2011). Additionally, it provides an opportunity for OUD intervention prior to a person 
experiencing a potentially fatal overdose.  
We also encountered several challenges that have resulted in limitations to our original 
plan. Our inability to establish and agreement with the PDMP could lead to holes in the data 
despite our identification of the Surescripts database and ability to obtain Medicaid billing data, 
the PDMP includes all prescriptions dispensed within Indiana, where the other two databases 
will only provide information for people with specific types of private insurance and Medicaid. 
Despite this, we are confident that the majority of opioid prescriptions will be captured due to 
the large number of patients enrolled in the pilot with Medicaid or Medicaid eligibility 
(approximately 85%) and the high rate of Medicaid enrollment among those with a substance 
use disorder in general (Buck, 2011). Despite having access to these other data sources, we are 
in contact with and continuing to try and establish a data sharing agreement with the PDMP. 
We are hopeful this can be accomplished before data are required for the final analyses. While 
accessing the PDMP data would be an improvement, missing data is an unfortunate fact of 
working with administrative systems that we will need to account for. While the use of 
secondary data sources is a key limitation of the study overall, unobtrusive data collection 
methods are preferred in pragmatic trials because remove the burden and artificial aspects of 
data collection follow-up (Ford & Norrie, 2016). Furthermore, the other secondary data sources 
we are utilizing will provide a rich array of data on a wide variety of health and social outcomes 
that are just as important for demonstrating benefits of POINT to stakeholders, which is a key 
goal of pragmatic trials (Glasgow, 2013; Maclure, 2009; Roland & Torgerson, 1998). Finally, the 
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change in the admission to a discharge time eligibility indicator could be considered 
problematic if ED staff are able to hold off a patient discharge during a control shift so that the 
patient can receive PRC services. However, this is unlikely considering ED staff are not fully 
aware of the trial procedures that determine eligibility, whether a POINT or SC arm is running 
recruitment, or what the differences between the two arms are in terms of patient treatment. 
The reduction from three to two hospitals harms the generalizability of the subsequent 
trial by reducing the number of locations from which our sample will be drawn (Roland & 
Torgerson, 1998; Ware & Hamel, 2011). Moreover, decreasing the number of hospitals will 
reduce our ability to learn from these modifications and how they might impact patient 
outcomes. Adaptation is the rule rather than the exception when it comes to program 
implementation (Aarons et al., 2012; Allen, Linnan, & Emmons, 2012), and Milestone 1’s results 
demonstrate adaptation of POINT is likely to occur at each location in order to ensure an 
optimal fit within its specific context. While these unplanned adaptations are likely to improve 
generalizability of the results, we must ensure the hospitals are delivering an intervention that 
is recognizable as POINT in both locations. To ensure this, we will be conducting fidelity reviews 
throughout the subsequent trial, documenting deviations and providing guidance for course 
correction when necessary.  
Also concerning Milestone 1, there is a possibility that the inability to replicate three of 
the 13 identified critical ingredients of the original POINT program (see Table 1) might 
negatively impact the intervention’s resulting effectiveness. For instance, lack of dedicated ED 
office space could lead to weaker relationships between POINT and ED staff that could benefit 
care provided. Furthermore, lack of a formal relationship and walk in hours with a MAT 
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provider means coaches will be required to invest more of their time into health system 
navigation. And, this will in turn limit time available to provide encouragement and support, 
which is a central function of their profession (Sightes et al., 2017; White & Evans, 2014). While 
coaches do have access to a provider of injectable naltrexone, it is likely very few patients will 
be ready for or accepting of this option because, unlike methadone or buprenorphine, it 
requires they go through a painful detoxification process prior to administration (Sigmon, 
Bisaga, Nunes, O’Connor, Kosten, & Woody). That said, at the time of this writing, we are in the 
process of establishing a formal referral process to a local buprenorphine provider that could 
potentially ease this issue.  
While we met Milestone 2’s recruitment goal, we did not include SC patients as a target, 
and we were low on enrollment in that arm. This has resulted in three additional modifications 
to protocols for the resulting trial. We have (1) modified our SC recruitment script in reaction to 
these low numbers, and we have seen an improvement in recruitment interactions as a result. 
To ensure we are better able to identify and engage these patients, we will be (2) conducting 
in-services with ED staff and (3) receiving weekly ED admission reports (previous data were 
based on staff recognition and tracking) to analyze and correct for any recognizable patterns of 
missed patients (e.g., change in staffing, re-training of research staff, ED staff re-education of 
POINT services). 
Finally, the inability to obtain secondary data to assess Milestone 3 was perhaps the 
most significant challenge encountered in the pilot, as these data would have been useful for 
predicting POINT’s ability to connect patients to MAT—the intervention’s primary goal. 
Typically, this type of pilot information might be used to adjust the sample size for the resulting 
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trial (Lancaster, Dodd, & Williamson, 2004). However, our sample size calculation was based on 
the subsequent overdose, which is a more distal outcome. As such, we will likely be able to 
detect a difference in the groups if it exists given the data indicating the early successes of the 
original Eskenazi program used to assess Milestone 3.  
5.1 Conclusions 
The pilot described in this paper has laid the groundwork for a large pragmatic trial of 
POINT. If successful, this trial will support the evidence-base for the novel and growing practice 
of ED-based peer support services for connecting people living with OUD to MAT. The 
pragmatic approach we are taking was made possible by capitalizing on opportunities 
presented by STR funding, and it is likely to lead to faster and more sustainable results with 
greater generalizability than a traditional clinical trial would. Researchers seeking to make an 
impact on the opioid crisis should consider taking advantage of similar opportunities that will 
become available as subsequent opioid-related funding is inevitably released.  
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